Table 5.
Baseline characteristics of patients grouped according to the first-year posttransplant parathormone levels.
| Resolved hyperparathyroidism(n = 161) | Persistent hyperparathyroidism(n = 73) | P value | |
|---|---|---|---|
| Age mean (±SD) | 41.2 (±13.0) | 40.6 (±12.2) | 0.54 |
| Sex F/M (n) | 57/104 | 31/42 | 0.08 |
| Vintage, (month) med (min-max) | 42 (0–221) | 52 (0–248) | 0.02 |
| eGFR mean (±SD) | 74.5 (±24.3) | 75.2 (±26.2) | 0.34 |
| Ca, mmol/L mean (±SD) | 2.35 (±0.16) | 2.49 (±0.17) | 0.004 |
| P, mmol/L mean (±SD) | 1.03 (±0.16) | 1.00 (±0.19) | 0.72 |
| Mg, mmol/L mean (±SD) | 0.85 (±0.10) | 0.85 (±0.11) | 0.97 |
| 25-OH-D, nmol/L mean (±SD) | 81.4 (±29.7) | 79.4 (±25.9) | 0.44 |
| Pre Tx iPTH, ng/L med (min-max) | 470.2 (60.2–2755.1) | 745.1 (132.1–2340.0) | <0.001 |
| ALP, µkat/L mean (±SD) | 1.38 (±0.48) | 1.63 (±0.93) | <0.001 |
| Cdx2 CC/CT/TT (%) | 74.5/23.0/2.5 | 34.3/47.9/17.8 | <0.01 |
| Fok1 AA/AG/GG (%) | 8.1/47.2/44.7 | 11.0/32.9/56.1 | 0.21 |
| Bsm1 CC/CT/TT (%) | 36.6/44.8/18.6 | 35.6/39.7/24.7 | 0.56 |
| Apa1 CC/CA/AA (%) | 24.8/40.4/34.8 | 16.4/39.8/43.8 | 0.86 |
| Taq1 AA/AG/GG (%) | 41.0/42.2/16.8 | 35.6/41.1/23.3 | 0.95 |